Log in to save to my catalogue

Galantamine ameliorates experimental pancreatitis

Galantamine ameliorates experimental pancreatitis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_637ce3daf8364f509c994bd8ab365cf4

Galantamine ameliorates experimental pancreatitis

About this item

Full title

Galantamine ameliorates experimental pancreatitis

Publisher

England: Springer

Journal title

Molecular Medicine, 2023-10, Vol.29 (1), p.149-149, Article 149

Language

English

Formats

Publication information

Publisher

England: Springer

More information

Scope and Contents

Contents

Acute pancreatitis is a common and serious inflammatory condition currently lacking disease modifying therapy. The cholinergic anti-inflammatory pathway (CAP) is a potent protective anti-inflammatory response activated by vagus nerve-dependent α7 nicotinic acetylcholine receptor (α7nAChR) signaling using splenic CD4
T cells as an intermediate. A...

Alternative Titles

Full title

Galantamine ameliorates experimental pancreatitis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_637ce3daf8364f509c994bd8ab365cf4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_637ce3daf8364f509c994bd8ab365cf4

Other Identifiers

ISSN

1528-3658,1076-1551

E-ISSN

1528-3658

DOI

10.1186/s10020-023-00746-y

How to access this item